LifeStance Health (LFST) Leases (2020 - 2026)

LifeStance Health (LFST) has 6 years of Leases data on file, last reported at $151.5 million in Q1 2026.

• Quarterly Leases rose 2.34% year-over-year to $151.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $151.5 million (up 2.34% YoY) and the FY2025 annual result came in at $149.7 million, up 1.25% from the prior year.
• Leases improved to $151.5 million in Q1 2026 per LFST's latest filing, from $149.7 million in the prior quarter.
• Across five years, Leases topped out at $199.4 million in Q4 2022 and bottomed at $143.2 million in Q2 2025.
• The 5-year median for Leases is $157.5 million (2024), against an average of $164.7 million.
• The widest annual swing landed in 2024, when Leases fell 16.29%; it then gained 2.34% in 2026.
• Tracing LFST's Leases over 5 years: stood at $199.4 million in 2022, then fell by 14.4% to $170.7 million in 2023, then decreased by 13.37% to $147.9 million in 2024, then advanced by 1.25% to $149.7 million in 2025, then gained by 1.21% to $151.5 million in 2026.
• Per Business Quant, the three latest LFST Leases figures stand at $151.5 million (Q1 2026), $149.7 million (Q4 2025), and $145.7 million (Q3 2025).

Peer Comparison